298 related articles for article (PubMed ID: 33095310)
1. Porto-sinusoidal vascular disease with portal hypertension versus liver cirrhosis: differences in imaging features on CT and hepatobiliary contrast-enhanced MRI.
Kang JH; Kim DH; Kim SY; Kang HJ; Lee JB; Kim KW; Lee SS; Choi J; Lim YS
Abdom Radiol (NY); 2021 May; 46(5):1891-1903. PubMed ID: 33095310
[TBL] [Abstract][Full Text] [Related]
2. Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder.
Lampichler K; Semmler G; Wöran K; Simbrunner B; Jachs M; Hartl L; Bauer DJM; Balcar L; Burghart L; Trauner M; Tamandl D; Ba-Ssalamah A; Mandorfer M; Reiberger T; Scheiner B; Scharitzer M
Eur Radiol; 2023 Feb; 33(2):1422-1432. PubMed ID: 36166087
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced CT and liver surface nodularity for the diagnosis of porto-sinusoidal vascular disorder: A case-control study.
Valainathan SR; Sartoris R; Elkrief L; Magaz M; Betancourt F; Pellegrino S; Nivolli A; Dioguardi Burgio M; Flattet Y; Terraz S; Drilhon N; Lazareth M; Herrou J; Bruno O; Payance A; Plessier A; Durand F; Ronot M; Valla DC; Paradis V; Garcia-Pagan JC; Vilgrain V; Rautou PE
Hepatology; 2022 Aug; 76(2):418-428. PubMed ID: 35092315
[TBL] [Abstract][Full Text] [Related]
4. Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension.
Elkrief L; Lazareth M; Chevret S; Paradis V; Magaz M; Blaise L; Rubbia-Brandt L; Moga L; Durand F; Payancé A; Plessier A; Chaffaut C; Valla D; Malphettes M; Diaz A; Nault JC; Nahon P; Audureau E; Ratziu V; Castera L; Garcia Pagan JC; Ganne-Carrie N; Rautou PE;
Hepatology; 2021 Jul; 74(1):364-378. PubMed ID: 33345307
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive differentiation of porto-sinusoidal vascular disorder from cirrhosis: a systematic review.
Giri S; Singh A; Roy A; Patel RK; Tripathy T; Angadi S
Abdom Radiol (NY); 2023 Jul; 48(7):2340-2348. PubMed ID: 37119294
[TBL] [Abstract][Full Text] [Related]
6. Splenic-hepatic elastography index is useful in differentiating between porto-sinusoidal vascular disease and cirrhosis in patients with portal hypertension.
Ferreira-Silva J; Gaspar R; Liberal R; Cardoso H; Macedo G
Dig Liver Dis; 2023 Jan; 55(1):75-80. PubMed ID: 36280435
[TBL] [Abstract][Full Text] [Related]
7. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease.
Nicoară-Farcău O; Rusu I; Stefănescu H; Tanțău M; Badea RI; Procopeț B
World J Gastroenterol; 2020 Jun; 26(22):3000-3011. PubMed ID: 32587444
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of transient elastography in differentiation between porto-sinusoidal vascular liver disease and compensated cirrhosis.
Zhang G; Ma L; Fu L; Li M; He F; Feng L; Wang M; Jia J; Wang Y; Zhao X
Liver Int; 2023 Nov; 43(11):2513-2522. PubMed ID: 37614162
[TBL] [Abstract][Full Text] [Related]
10. Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features.
Kozaka K; Kobayashi S; Yoneda N; Kitao A; Yoshida K; Inoue D; Ogi T; Koda W; Sato Y; Gabata T; Matsui O
Eur Radiol; 2019 Dec; 29(12):6489-6498. PubMed ID: 31278576
[TBL] [Abstract][Full Text] [Related]
11. Porto-sinusoidal vascular disorder.
De Gottardi A; Sempoux C; Berzigotti A
J Hepatol; 2022 Oct; 77(4):1124-1135. PubMed ID: 35690264
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune biomarkers in porto-sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology.
Cerda Reyes E; González-Navarro EA; Magaz M; Muñoz-Sánchez G; Diaz A; Silva-Junior G; Triguero A; Lafoz E; Campreciós G; Orts L; Perez-Campuzano V; Seijo S; Rubio L; Turon F; Baiges A; Hernández-Gea V; Álvarez-Larran A; Juan M; Garcia-Pagan JC
Liver Int; 2021 Sep; 41(9):2171-2178. PubMed ID: 34173316
[TBL] [Abstract][Full Text] [Related]
13. Paediatric porto-sinusoidal vascular disease: Two different clinical phenotypes with subtle histological differences.
Di Giorgio A; Matarazzo L; Sonzogni A; Nicastro E; Pietrobattista A; Cananzi M; Gaio P; Sciveres M; Di Leo G; Iorio R; Marseglia A; Carioli G; Maggiore G; Guido M; D'Antiga L
Liver Int; 2023 Jul; 43(7):1523-1536. PubMed ID: 37157951
[TBL] [Abstract][Full Text] [Related]
14. Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT.
De Vos N; Sartoris R; Cauchy F; Rautou PE; Vilgrain V; Ronot M
Abdom Radiol (NY); 2020 Feb; 45(2):365-372. PubMed ID: 31797023
[TBL] [Abstract][Full Text] [Related]
15. Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma.
Park HJ; Byun JH; Kang JH; Kang HJ; Yu E; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
Eur J Radiol; 2021 Jun; 139():109730. PubMed ID: 33930719
[TBL] [Abstract][Full Text] [Related]
16. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study.
Kudo M; Zheng RQ; Kim SR; Okabe Y; Osaki Y; Iijima H; Itani T; Kasugai H; Kanematsu M; Ito K; Usuki N; Shimamatsu K; Kage M; Kojiro M
Intervirology; 2008; 51 Suppl 1():17-26. PubMed ID: 18544944
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte-specific contrast-enhanced MRI findings of focal nodular hyperplasia-like nodules in the liver following chemotherapy in pediatric cancer patients.
Özcan HN; Karçaaltıncaba M; Seber T; Yalçın B; Oğuz B; Akyüz C; Haliloğlu M
Diagn Interv Radiol; 2020 Jul; 26(4):370-376. PubMed ID: 32490830
[TBL] [Abstract][Full Text] [Related]
19. TAFRO syndrome complicated by porto-sinusoidal vascular liver disease with portal hypertension: a case report.
Hayashi M; Wada J; Fujita M; Asano T; Matsuoka N; Fujita Y; Temmoku J; Matsumoto H; Yashio-Furuya M; Sato S; Kobayashi H; Watanabe H; Ryoichiro K; Waragai Y; Suzuki E; Kiko Y; Abe K; Takahashi A; Masuda T; Hashimoto Y; Migita K; Ohira H
Clin J Gastroenterol; 2021 Dec; 14(6):1711-1717. PubMed ID: 34487333
[TBL] [Abstract][Full Text] [Related]
20. Porto-sinusoidal vascular disorder in chronic HBV: A significant coexistence not to be overlooked.
Olivas P; Perez-Campuzano V; Orts L; Montironi C; Magaz M; Ruiz P; Shalaby S; Ojeda A; Rosich P; Baiges A; Turon F; Lens S; García Pagán JC; Hernández-Gea V
JHEP Rep; 2024 Mar; 6(3):100996. PubMed ID: 38384671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
